Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma.
2021
We have experienced several paradigm shifts and substantial changes in the treatment of metastatic renal cell carcinoma (mRCC) over the last two decades. Combination therapy with immune checkpoint ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
80
References
0
Citations
NaN
KQI